Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Jun 18, 2010

Premium

Predictive Biosciences announced this week that Jay Moorin has joined its board of directors.

Moorin is a founding partner at ProQuest Investments, which led a recent Series C funding round through which Predictive raised $25 million (see related story, this issue).

Prior to founding ProQuest, Moorin was CEO of Magainin Pharmaceuticals (now Genaera), and prior to that he was managing director of healthcare banking at Bear Stearns.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.